GRI Bio, Inc.
GRI
$2.31
$0.062.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.66M | -3.36M | -2.89M | -3.05M | -1.95M |
| Total Depreciation and Amortization | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 79.00K | 478.00K | 53.00K | 231.00K | 49.00K |
| Change in Net Operating Assets | -392.00K | 567.00K | -328.00K | 1.08M | -101.00K |
| Cash from Operations | -2.97M | -2.31M | -3.17M | -1.74M | -2.00M |
| Capital Expenditure | -3.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.00K | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.00M | 1.62M | 5.94M | -- | 2.38M |
| Repurchase of Common Stock | -1.00K | -- | 0.00 | -1.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -851.00K | -374.00K | -934.00K | -10.00K | -96.00K |
| Cash from Financing | 7.15M | 1.25M | 5.01M | -11.00K | 2.28M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.17M | -1.07M | 1.84M | -1.75M | 282.00K |